Giant Cystadenoma of Prostate

Thomas, Ajit J.; Mistry, Yogesh; Gopalakrishnan, Ganesh
January 2009
Urology Journal;Jan2009, Vol. 6 Issue 1, p57
Academic Journal
The article presents a case study of a man suffering from giant prostate cystadenoma with recurrent growth due to incomplete tumor resection. The man presented to a medical college in May 2007 with a mass in his lower abdomen. Immunohistochemistry examination revealed lining epithelium showing strong immunostaining for monoclonal prostate-specific antigen.


Related Articles

  • NSAIDs may lower PSA levels.  // Hem/Onc Today;12/10/2008, Vol. 9 Issue 22, p27 

    The article focuses on a study which found that taking aspirin and other non-steroidal anti-inflammatory drugs (NSAID) may lower prostate specific antigen (PSA) levels especially in men with prostate cancer. Study participants included men aged 40 years or older who had been scheduled for...

  • High PSA Not Always a Negative Outcome Predictor.  // Renal & Urology News;Aug2010, Vol. 9 Issue 8, p10 

    The article reports that prostate cancer patients who have high prostate-specific antigen (PSA) levels are not always a negative outcome predictor.

  • Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report. Hingorani, Rittu; Young, Jessica; Alweis, Richard // Journal of Community Hospital Internal Medicine Perspectives (JC;2014, Vol. 4 Issue 5, p1 

    Background: Neuroendocrine prostate cancer is rare but lethal. It is one of the most common extra pulmonary manifestations of small cell cancer. Case presentation: Here we present a case report of a 53-year-old male who presents with a mixed adenocarcinoma and neuroendocrine prostate tumor on a...

  • Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy. Joo Yong Lee; Dae Hun Lee; Nam Hoon Cho; Koon Ho Rha; Young Deuk Choi; Sung Joon Hong; Seung Choul Yang; Kang Su Cho // Yonsei Medical Journal;Mar2014, Vol. 55 Issue 2, p316 

    Purpose: To analyze overall survival (OS), prostate cancer (PCa)-specific survival (PCaSS), and non-PCaSS according to the Charlson Comorbidity Index (CCI) after radical prostatectomy (RP) for PCa. Materials and Methods: Data from 336 patients who had RP for PCa between 1992 and 2005 were...

  • Pomegranate juice extract may increase PSA doubling time. Volansky, Rob // Hem/Onc Today;3/10/2011, Vol. 12 Issue 5, p18 

    The article discusses a research study, led by Doctor Michael A. Carducci, which found that pomegranate juice extract may increase prostate-specific antigen (PSA) doubling time in non-metastatic patients with prostate cancer.

  • PSADT Predicts Post RP Death.  // Renal & Urology News;Apr2010, Vol. 9 Issue 4, p20 

    The article presents a study, conducted by Emmanuel S. Antonarakis of Johns Hopkins University in Baltimore, Maryland, which shows that prostate-specific antigen doubling time (PSADT) is the most significant predictor of 15-year overall survival in men experiencing biochemical recurrence after...

  • Denosumab Delays Bone Metastases.  // Renal & Urology News;Aug2013, Vol. 12 Issue 8, p7 

    The article reports on a study by doctor Blair Egerdie and colleagues which revealed that denosumab delays the median time to the development of bone metastases in men, who have prostate-specific antigen (PSA) doubling time (PSADT) and non-metastatic castrate-resistant prostate cancer (CRPC).

  • Tumor Size Predicts Biochemical Recurrence Risk.  // Renal & Urology News;Jul2014, Vol. 13 Issue 7, p25 

    The article offers information on a study which discusses the use of maximal tumor diameter (MTD) to predict risk of prostate-specific antigen (PSA) failure among patients.

  • Palpable Tumors Plus Low PSA May Increase PCSM. CHARNOW, JODY A. // Renal & Urology News;Oct2014, Vol. 13 Issue 10, p11 

    The article reports that palpable prostate cancer (PCa) with low prostate-specific antigen (PSA) increase the risk of cancer-related death.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics